the survival of 229 patients treated with adjuvant i.v . cyclophosphamide , methotrexate , and 5-fluorouracil ( cmf ) after surgery for primary breast cancer was analyzed according to three administration-related factors : total number of cycles received , time elapsed between surgery and start of chemotherapy , and dose intensity of treatment .
C0016360
5-fluorouracil
C0950521
cmf